CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hunan Dajiaweikang Phrmctcl ndstry C Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hunan Dajiaweikang Phrmctcl ndstry C Ltd
No. 30, Fuling Road, Yuelu District
Phone: +86 73184170075p:+86 73184170075 CHANGSHA, HUN  410000  China Ticker: 301126301126
Business Summary
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd is a China-based company primarily engaged in the distribution and retail of pharmaceuticals, biological products, and medical devices. The Company mainly operates in four businesses. The distribution business includes direct sales and allocation models, primarily dealing in new and special drugs such as anti-tumor drugs, immunomodulatory drugs, cardiovascular drugs, respiratory drugs, and antiviral drugs. The retail business mainly operates direct-to-patient (DTP) pharmacies and Special Service pharmacies. The pharmaceutical manufacturing business is primarily engaged in the research and development of original chemical drugs, innovative traditional Chinese medicines, first-to-market generic drugs, and health products. The medical service business is primarily engaged in reproductive hospital-related businesses. The Company mainly conducts its businesses within domestic market.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
5912 Drug stores and proprietary stores
5499 Miscellaneous food stores
5122 Drugs, drug proprietaries, and druggists' sundries
5047 Medical, dental, and hospital equipment and supplies
8069 Specialty hospitals, except psychiatric
8731 Commercial physical and biological research

General Information
Number of Employees: 4,887 (As of 12/31/2024)
Outstanding Shares: 205,403,200 (As of 9/30/2025)
Shareholders: 14,261
Stock Exchange: SHE
Fax Number: +86 73188911758


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026